Regnerative medicine developer Frequency Therapeutics has set the range for an initial public offering that will raise $107m if it floats at the high end.

CapitalG-backed Airbnb, valued at $31bn as of 2017, has declared it plans to list its shares next year, and looks likely to choose a direct listing.

Fosun-backed Shanghai Henlius Biotech has priced shares at the bottom of its range to raise $410m in its initial public offering ahead of public trading next week.

Haldor Topsøe remains the largest shareholder of cancer treatment developer IGM Biosciences, whose shares have risen more than 50% since it floated yesterday.

Lundbeck, Pfizer and Alexandria Real Estate Equities are all in line for exits after Imara revealed it has confidentially filed for an initial public offering.

The developing digital health sector has had to wait almost three years for the public markets to open up to it, but when they did, it was corporate venturing portfolio companies that were first through the flotation exit doors.

“WeWork’s Bonkers IPO,” said Fortune’s daily newsletter. “The Weirdness of WeWork’s IPO Filing”, sister publication CEO Daily called it, adding: “If a recession is coming, the WeWork IPO filing… will be a fitting capstone for the peak.”

Pfizer spinoff Springworks, which also counts GlaxoSmithKline as an investor, secured $162m in an initial public offering that followed $228m of funding.

We Company's largest investor is set to buy up about 25% of the shares in the IPO, which is likely to reduce its valuation from $47bn to as little as $15bn.

Alphabet, Baidu, Microsoft and Qualcomm all notched up exits as the cloud services provider floated above a range that had already been increased.